Renal protective effect of Samsca in patients with new-onset acute heart failure
Not Applicable
- Conditions
- Acute heart failure
- Registration Number
- JPRN-UMIN000036417
- Lead Sponsor
- Kansai Medical University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 122
Inclusion Criteria
Not provided
Exclusion Criteria
Concomitant acute coronary syndrome History of tolvaptan treatment before hospitalization Hemodialysis patient
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of worsening renal function during hospitalization between tolvaptan group and furosemide group
- Secondary Outcome Measures
Name Time Method Composite outcome (all cause mortality, heart failure rehospitalization and renal impairment) All cause mortality Heart failure rehospitalization Renal impairment